Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-01-12

Clinical Trial Update: Management of Eczema by Specific Probiotic Strains [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating management of eczema using specific probiotic strains has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Probiotic strains for eczema management (unspecified)

Snippet

Sponsor: Agentschap NL | Conditions: Eczema, Atopic Dermatitis | Phase 3 | Status: WITHDRAWN